Confirmed: Key heart medications safe to use for COVID-19 patients

The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.

Thumbnail

Why early rhythm control therapy is so important for atrial fibrillation patients

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

Thumbnail

Shear wave imaging ‘extremely promising’ for assessment of myocardial stiffness in heart transplant recipients

The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.

Thumbnail

Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

Thumbnail

How to predict a CVD patient’s risk of total, colorectal and lung cancer

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

Thumbnail

Burnout in cardiology: Most pediatric heart nurses feel exhausted, with 30% eyeing a career change

Nurses are unhappy with their working conditions, which leads to stress and exhaustion. 

Thumbnail

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response. 

Thumbnail

AHA condemns Trump administration’s latest attack on ACA

The American Heart Association noted that the Affordable Care Act has provided “invaluable patient protections for millions of Americans with pre-existing conditions.”